Literature DB >> 15066068

Alcohol intake and risk of dementia.

Jose A Luchsinger1, Ming-Xin Tang, Maliha Siddiqui, Steven Shea, Richard Mayeux.   

Abstract

OBJECTIVES: To examine the association between intake of alcoholic beverages and risk of Alzheimer's disease (AD) and dementia associated with stroke (DAS) in a cohort of elderly persons from New York City.
DESIGN: Cohort study.
SETTING: The Washington Heights Inwood-Columbia Aging Project. PARTICIPANTS: Nine hundred eighty community-dwelling individuals aged 65 and older without dementia at baseline and with data on alcohol intake recruited between 1991 and 1996 and followed annually. MEASUREMENTS: Intake of alcohol was measured using a semiquantitative food frequency questionnaire at baseline. Subjects were followed annually, and incident dementia was diagnosed using Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria and classified as AD or DAS.
RESULTS: After 4 years of follow-up, 260 individuals developed dementia (199 AD, 61 DAS). After adjusting for age, sex, apolipoprotein E (APOE)-epsilon 4 status, education, and other alcoholic beverages, only intake of up to three daily servings of wine was associated with a lower risk of AD (hazard ratio=0.55, 95% confidence interval=0.34-0.89). Intake of liquor, beer, and total alcohol was not associated with a lower risk of AD. Stratified analyses by the APOE-epsilon 4 allele revealed that the association between wine consumption and lower risk of AD was confined to individuals without the APOE-epsilon 4 allele.
CONCLUSIONS: Consumption of up to three servings of wine daily is associated with a lower risk of AD in elderly individuals without the APOE epsilon-4 allele.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15066068     DOI: 10.1111/j.1532-5415.2004.52159.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  94 in total

1.  The benefits of apolipoprotein E epsilon4 screening to research.

Authors:  Serge Gauthier
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

Review 2.  Current therapeutic targets for the treatment of Alzheimer's disease.

Authors:  Joshua D Grill; Jeffrey L Cummings
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

Review 3.  Moderate ethanol preconditioning of rat brain cultures engenders neuroprotection against dementia-inducing neuroinflammatory proteins: possible signaling mechanisms.

Authors:  Michael A Collins; Edward J Neafsey; Kewei Wang; Nicholas J Achille; Robert M Mitchell; Sreevidya Sivaswamy
Journal:  Mol Neurobiol       Date:  2010-04-28       Impact factor: 5.590

4.  Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application.

Authors:  H K Lückhoff; M Kidd; S J van Rensburg; D P van Velden; M J Kotze
Journal:  Metab Brain Dis       Date:  2016-02       Impact factor: 3.584

Review 5.  Diet and Alzheimer's disease.

Authors:  José A Luchsinger; James M Noble; Nikolaos Scarmeas
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

Review 6.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

7.  Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.

Authors:  Lap Ho; Mario G Ferruzzi; Elsa M Janle; Jun Wang; Bing Gong; Tzu-Ying Chen; Jessica Lobo; Bruce Cooper; Qing Li Wu; Stephen T Talcott; Susan S Percival; James E Simon; Giulio Maria Pasinetti
Journal:  FASEB J       Date:  2012-10-24       Impact factor: 5.191

8.  Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease.

Authors:  Jun Wang; Lap Ho; Wei Zhao; Kenjiro Ono; Clark Rosensweig; Linghong Chen; Nelson Humala; David B Teplow; Giulio M Pasinetti
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

9.  Association of alcohol consumption with brain volume in the Framingham study.

Authors:  Carol Ann Paul; Rhoda Au; Lisa Fredman; Joseph M Massaro; Sudha Seshadri; Charles Decarli; Philip A Wolf
Journal:  Arch Neurol       Date:  2008-10

10.  AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.

Authors:  Valérie Vingtdeux; Luca Giliberto; Haitian Zhao; Pallavi Chandakkar; Qingli Wu; James E Simon; Elsa M Janle; Jessica Lobo; Mario G Ferruzzi; Peter Davies; Philippe Marambaud
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.